Nicklas, André P <br/><br/>
Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC).  [electronic resource] 

 -  Advances in therapy  11 2018 
 - 2054-2068 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1865-8652 
<br/><br/><label>Standard No.: </label>10.1007/s12325-018-0789-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Biomarkers, Tumor--analysis<br/>Calcium-Binding Proteins--analysis<br/>Calgranulin A--analysis<br/>Disease Progression<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Male<br/>Neoplasm Grading<br/>Neoplasm Invasiveness--diagnosis<br/>Neoplasm Recurrence, Local--diagnosis<br/>Prognosis<br/>Reproducibility of Results<br/>Retrospective Studies<br/>Risk Assessment--methods<br/>Urinary Bladder Neoplasms--diagnosis